Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Conway

Showing results (441-450 of 711) with videos related to

Pageof 72
Sort By:
Kidney International Reports|February 22, 2021
A National Registry Study of Patient and Renal Survival in Adult Nephrotic SyndromeAnna Kolb, Peter J Gallacher, Jacqueline Campbell, et al.
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
BMC Psychiatry|December 29, 2019
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trialBoadie W Dunlop, Sagar V Parikh, Anthony J Rothschild, et al.
Molecular Therapy. Methods & Clinical Development|May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy productsJessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Psychiatry Research|December 28, 2020
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depressionAnthony J Rothschild, Sagar V Parikh, Daniel Hain, et al.
Nature Genetics|November 24, 2020
Integrated molecular drivers coordinate biological and clinical states in melanomaJake R Conway, Felix Dietlein, Amaro Taylor-Weiner, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3Han-Cheng Zhang, Kimberly B White, Hong Ye, et al.
Jac-Antimicrobial Resistance|October 11, 2023
Exploring drivers and challenges influencing antibiotic prescribing in outpatient settings and possible mitigation strategies in the United Arab Emirates: a qualitative studyAhmed A Sadeq, Farah Ahmed Issa, Mina Bakhit, et al.
Journal of the American Society of Nephrology : JASN|September 26, 2020
Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney DiseaseBryan R Conway, Eoin D O'Sullivan, Carolynn Cairns, et al.
Pageof 72

Showing results (441-450 of 711) with videos related to

Sort By:
Pageof 72
Kidney International Reports|February 22, 2021
A National Registry Study of Patient and Renal Survival in Adult Nephrotic SyndromeAnna Kolb, Peter J Gallacher, Jacqueline Campbell, et al.
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Kidney International|April 17, 2016
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetesBoris B Betz, Sara J Jenks, Andrew D Cronshaw, et al.
BMC Psychiatry|December 29, 2019
Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trialBoadie W Dunlop, Sagar V Parikh, Anthony J Rothschild, et al.
Molecular Therapy. Methods & Clinical Development|May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy productsJessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Psychiatry Research|December 28, 2020
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depressionAnthony J Rothschild, Sagar V Parikh, Daniel Hain, et al.
Nature Genetics|November 24, 2020
Integrated molecular drivers coordinate biological and clinical states in melanomaJake R Conway, Felix Dietlein, Amaro Taylor-Weiner, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3Han-Cheng Zhang, Kimberly B White, Hong Ye, et al.
Jac-Antimicrobial Resistance|October 11, 2023
Exploring drivers and challenges influencing antibiotic prescribing in outpatient settings and possible mitigation strategies in the United Arab Emirates: a qualitative studyAhmed A Sadeq, Farah Ahmed Issa, Mina Bakhit, et al.
Journal of the American Society of Nephrology : JASN|September 26, 2020
Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney DiseaseBryan R Conway, Eoin D O'Sullivan, Carolynn Cairns, et al.
Pageof 72